These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 31736243)
1. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Kharod SM; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Morris CG; Bradfield S; Sandler ES; Bradley JA Pediatr Blood Cancer; 2020 Feb; 67(2):e28080. PubMed ID: 31736243 [TBL] [Abstract][Full Text] [Related]
2. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years. Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. Weber DC; Badiyan S; Malyapa R; Albertini F; Bolsi A; Lomax AJ; Schneider R Neuro Oncol; 2016 Feb; 18(2):236-43. PubMed ID: 26323608 [TBL] [Abstract][Full Text] [Related]
6. Local Control After Proton Therapy for Pediatric Chordoma. Indelicato DJ; Rotondo RL; Mailhot Vega RB; Holtzman AL; Looi WS; Morris CG; Sandler ES; Aldana PR; Bradley JA Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1406-1413. PubMed ID: 33253819 [TBL] [Abstract][Full Text] [Related]
7. Pencil beam scanned protons for the treatment of patients with Ewing sarcoma. Weber DC; Murray FR; Correia D; Bolsi A; Frei-Welte M; Pica A; Lomax AJ; Schneider R; Bachtiary B Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28627000 [TBL] [Abstract][Full Text] [Related]
8. Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis. Uezono H; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Bradfield SM; Morris CG; Bradley JA Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):974-981. PubMed ID: 32437922 [TBL] [Abstract][Full Text] [Related]
9. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526 [TBL] [Abstract][Full Text] [Related]
10. Surgery and protontherapy in Grade I and II skull base chondrosarcoma: A comparative retrospective study. Simon F; Feuvret L; Bresson D; Guichard JP; El Zein S; Bernat AL; Labidi M; Calugaru V; Froelich S; Herman P; Verillaud B PLoS One; 2018; 13(12):e0208786. PubMed ID: 30557382 [TBL] [Abstract][Full Text] [Related]
11. Local recurrence of Ewing sarcoma: Is wide excision an acceptable treatment? Xue R; Lewis VO; Moon BS; Lin PP J Surg Oncol; 2019 Sep; 120(4):746-752. PubMed ID: 31286523 [TBL] [Abstract][Full Text] [Related]
12. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage? Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574 [TBL] [Abstract][Full Text] [Related]
13. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience. Indelicato DJ; Vega RBM; Viviers E; Morris CG; Bradfield SM; Ranalli NJ; Bradley JA Int J Radiat Oncol Biol Phys; 2022 May; 113(1):161-165. PubMed ID: 35033584 [TBL] [Abstract][Full Text] [Related]
14. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis. Martin E; Radomski S; Harley EH Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068 [TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Long-Term Outcome of Primary Intracranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: 14 Cases From a Single Institution. Chen J; Jiang Q; Zhang Y; Yu Y; Zheng Y; Chen J; Zhao Y; Miao Z; Fan F; Wang Y World Neurosurg; 2019 Feb; 122():e1606-e1614. PubMed ID: 30496933 [TBL] [Abstract][Full Text] [Related]
16. The role of radiotherapy in local control of nonextremity Ewing sarcomas. Akagunduz OO; Kamer SA; Kececi B; Demirag B; Oniz H; Kantar M; Cetingul N; Sabah D; Anacak Y Tumori; 2016; 102(2):162-7. PubMed ID: 26917407 [TBL] [Abstract][Full Text] [Related]
18. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182 [TBL] [Abstract][Full Text] [Related]
20. Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma. Kacar M; Nagel MB; Liang J; Li Y; Neel MD; Lucas JT; McCarville MB; Santiago T; Pappo AS; Krasin MJ Cancer; 2024 May; 130(10):1836-1843. PubMed ID: 38271232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]